Polymeric Biomaterials Addressing The Rising Tide Of Chronic Diseases: Transformative Forces Shaping the Polymeric Biomaterials Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Polymeric Biomaterials Industry Market Size Be by 2025?
The market size of polymeric biomaterials has swiftly expanded in the previous years. An increase from $59.69 billion in 2024 to $70.18 billion in 2025 is expected, equating to a compound annual growth rate (CAGR) of 17.6%. The surge in growth can be credited to a rise in the demand for medical implants, improved biocompatibility, the emergence of tissue engineering, a hike in orthopedic surgeries, and the enhancement in drug delivery systems.

What's the Long-Term Growth Forecast for the Polymeric Biomaterials Market Size Through 2029?
The market size of polymeric biomaterials is projected to witness a swift expansion in the coming years, rising to $132.6 billion by 2029 with an annual growth rate of 17.2%. The anticipated growth in this period is largely driven by factors such as regenerative medicine, personalized medicine, environmental issues, 3D printing, managing chronic diseases, and minimally invasive surgery. The forthcoming period also predicts a rise in trends like advancements in polymer chemistry, groundbreaking innovations in biomedical engineering, regulatory clearances, incorporation of technology, and academic research.

View the full report here:
https://www.thebusinessresearchcompany.com/report/polymeric-biomaterials-global-market-report

What Are the Key Growth Drivers Fueling the Polymeric Biomaterials Market Expansion?
The expansion of the polymeric biomaterials market is anticipated to be driven by the increasing incidence of chronic diseases. Typically, chronic diseases are persistent, slowly progressing conditions that can last throughout an individual's lifetime. Various factors contribute to escalating chronic disease rates, including an aging population, lifestyle choices, economic strain, healthcare demands, and public health issues. Polymeric biomaterials play a crucial role in chronic disease treatment by providing inventive solutions that augment the efficiency of healthcare procedures and improve the quality of life for those living with long-term conditions. These materials are also integral in creating a variety of medical equipment and implants, such as stents, catheters, and joint replacements, all of which are critical to the management of chronic diseases necessitating surgical solutions. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, stated in September 2023 that annually, chronic diseases cause 41 million deaths globally, amounting to 74% of all fatalities. This figure includes 17.9 million heart disease-related deaths, 9.3 million deaths due to cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the rising occurrence of chronic diseases is propelling the growth of the polymeric biomaterials market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15898&type=smp

What Are the Key Trends Driving Polymeric Biomaterials Market Growth?
Leading companies in the polymeric biomaterials sector are concentrating their efforts on creating different and cutting-edge solutions such as 3D printable biomaterials in order to enhance their competitive standing. These 3D printable biomaterials comprise a category of substances that are associated with three-dimensional (3D) printing methods to produce structures and instruments for medical usage. For example, Evonik Industries AG, a German chemical firm, introduced the VESTAKEEP iC4800 3DF in March 2022. This recently launched osteoconductive PEEK filament boosts fusion between bones and implants. It is a superior polymeric biomaterial specifically tailored for application in 3D-printed medical implants due to its biocompatibility and characteristics that encourage bone development. The VESTAKEEP iC4800 3DF is a ground-breaking osteoconductive PEEK filament that makes possible the 3D printing of bespoke implants with enhanced bone fusion, speeding up healing and recovery. This promotes better integration of the implant, faster patient recovery, bespoke implant designs, and widens Evonik's range of 3D printable biomaterials for medical applications.

How Is the Polymeric Biomaterials Market Segmented?
The polymeric biomaterials market covered in this report is segmented -

1) By Product: Polylactic Acid, Polyglycolic Acid, Polyurethanes, Polytetrafluoroethylene, ket*one, Polydioxanone, Other Products
2) By Application: Cardiovascular, Dental, Orthopedic, Plastic Surgery, Neurology, Other Applications
3) By End-User: Hospitals, Clinics, Other End-users

Subsegments:
1) By Polylactic Acid (PLA): PLA-Based Scaffolds, PLA-Based Sutures And Stents
2) By Polyglycolic Acid (PGA): PGA-Based Sutures, PGA-Based Scaffolds
3) By Polyurethanes: Polyurethane-Based Wound Dressings, Polyurethane-Based Implants
4) By Polytetrafluoroethylene (PTFE): PTFE-Based Vascular Grafts, PTFE-Based Membranes
5) By ket*one (PAEK): PAEK-Based Implants, PAEK-Based Prosthetics
6) By Polydioxanone (PDO): PDO-Based Sutures, PDO-Based Drug Delivery Systems
7) By Other Products: Biodegradable Polymers, Natural Polymers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15898&type=smp

Which Companies Are Leading the Charge in Polymeric Biomaterials Market Innovation?
Major companies operating in the polymeric biomaterials market are BASF SE, 3M Company, Medtronic plc, Toray Industries Inc., Evonik Industries AG, Covestro AG, Stryker Corporation, Solvay SA, DuPont Biomaterials, Arkema Group, Mitsubishi Chemical Holdings Inc., Celanese Corporation, Royal DSM, TEIJIN Limited, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Huafon Group, W. L. Gore & Associates Inc., Corbion NV, Integra LifeSciences Holdings Corporation, Victrex plc, Collagen Matrix, Berkeley Advanced Biomaterials, Bezwada Biomedical LLC, Covation Biomaterials, Starch Medical Inc.

Which Regions Are Leading the Global Polymeric Biomaterials Market in Revenue?
North America was the largest region in the polymeric biomaterials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymeric biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15898

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.